The same authors showed that the estimated penetrance of BC in women aged 80 years was 60.8% for BRCA1 and 63.1% for BRCA2 [160], compared with 13% of women in the general population that develop BC sometime in their lifetime. This evidence concerns the gene BRCA1 and breast cancer.